U.S. Tobacco Stock News

NasdaqGS:FIZZ
NasdaqGS:FIZZBeverage

What National Beverage (FIZZ)'s Resilient EPS and Rising Shipments Mean for Shareholders

National Beverage Corp. recently reported past third-quarter results showing sales of US$264.59 million and net income of US$41.21 million, with basic and diluted earnings per share of US$0.44, slightly higher than a year earlier despite modestly lower revenue. The company also cited a 7% increase in January shipments and encouraging early fourth-quarter volume trends, suggesting that new product introductions and its decision not to fully pass through tariffs to consumers are helping...
NasdaqGS:STBA
NasdaqGS:STBABanks

Is S&T Bancorp (STBA) Pricing Look Attractive After Recent Share Price Pullback?

If you are wondering whether S&T Bancorp at around US$40.20 is offering fair value or a possible bargain, you are not alone, and this article is designed to help you frame that question clearly. The stock has seen mixed recent returns, with a 1.3% decline over the last week and an 8.0% decline over the last 30 days, set against gains of 2.4% year to date, 8.5% over 1 year, 38.6% over 3 years and 42.6% over 5 years. Recent attention on regional banks, along with continuing investor focus on...
NasdaqGS:SIRI
NasdaqGS:SIRIMedia

Is Sirius XM Holdings (SIRI) Pricing Reflect Long Term Share Price Declines And DCF Upside Potential

If you are wondering whether Sirius XM Holdings is still worth a place in your portfolio at today’s price, this article walks through what the current market valuation might be implying. The stock recently closed at US$21.99, with returns of 3.3% over the past 30 days, 7.2% year to date, 2.0% over the last year, and longer term 3 year and 5 year returns of 32.5% and 56.9% declines respectively. This tells a very different story depending on your time frame. Recent coverage has focused on...
NasdaqGS:TERN
NasdaqGS:TERNPharmaceuticals

Terns Pharmaceuticals (TERN) Is Up 8.6% After Pipeline Update And Index Inclusion News

Terns Pharmaceuticals recently attracted renewed attention after updating its corporate presentation with refreshed pipeline timelines and milestones, while also being selected for inclusion in a STOXX benchmark index effective March 23, 2026. This combination of clearer development visibility, impending index inclusion, and investor focus on the upcoming earnings update has sharpened debate around the company’s long-term prospects and current financial pressures. With investors now closely...
NasdaqGM:MVIS
NasdaqGM:MVISElectronic

Assessing MicroVision (MVIS) Valuation After Full Year Earnings Reveal Weaker Sales And Ongoing Losses

MicroVision’s latest earnings draw investor focus MicroVision (MVIS) is back in the spotlight after reporting full year 2025 earnings, with sales of US$1.21 million compared with US$4.7 million a year earlier and a net loss of US$94.98 million. See our latest analysis for MicroVision. Despite the earnings update, MicroVision’s share price has faced pressure, with a 30 day share price return of 29.18% and a 1 year total shareholder return of 58.42%. This suggests momentum has been fading as...
NasdaqGS:CDXS
NasdaqGS:CDXSLife Sciences

Codexis (CDXS) Is Up 30.9% After Merck-Fueled Q4 Profit Beat And 2026 Revenue Guidance - Has The Bull Case Changed?

In March 2026, Codexis reported fourth-quarter 2025 results showing revenue of US$38.92 million and net income of US$9.6 million, reversing a prior-year loss and beating analyst expectations, alongside full-year 2025 revenue of US$70.39 million and guidance for 2026 revenue of US$72 million to US$76 million. The quarter was heavily influenced by a large technology transfer agreement with Merck and growing ECO Synthesis platform activity, which also underpins management’s view that existing...
NasdaqGS:WOOF
NasdaqGS:WOOFSpecialty Retail

Is It Time To Reconsider Petco Health and Wellness Company (WOOF) After The Recent Share Price Surge

This article examines whether Petco Health and Wellness Company, at around US$3.62, may represent a bargain or a value trap by exploring what the current share price might indicate about the business. The stock has recently experienced sharp moves, with returns of 52.1% over the last 7 days, 44.2% over the last 30 days, 27.0% year to date and 51.5% over the last year. However, the 3 year and 5 year returns show declines of 63.1% and 84.4%, which tells a very different story. These swings...
NYSE:ORI
NYSE:ORIInsurance

Old Republic Leadership Shift And Valuation Gap As Wordekemper Takes Helm

Old Republic International (NYSE:ORI) has appointed Doug Wordekemper as CEO of Old Republic Professional. The move is part of a broader organizational leadership change within the Professional division. The appointment brings a leader with extensive industry experience into a key role overseeing the Professional business. Old Republic International, through its Professional division, focuses on specialty insurance solutions for professional liability and related risks. Leadership changes in...
NasdaqCM:KARO
NasdaqCM:KAROSoftware

Karooooo (NasdaqCM:KARO) Valuation Check As Cartrack Crosses Two Million Subscriber Milestone

Subscriber milestone puts Karooooo (KARO) in focus Cartrack, a subsidiary of Karooooo (KARO), has surpassed two million active subscribers in South Africa. This milestone puts the group’s mobility SaaS model and customer-focused execution firmly on investors’ radar. See our latest analysis for Karooooo. Karooooo’s latest subscriber milestone lands after a period where the share price has moved steadily rather than sharply, with a 5.69% year to date share price return and a 19.93% one year...
NYSE:WEX
NYSE:WEXDiversified Financial

Is WEX (WEX) Offering Value After Recent Share Price Volatility And Mixed Valuation Signals

If you are wondering whether WEX at around US$159.95 is priced fairly or offering value, you are not alone. This article is built to help you assess that question using several valuation tools. The stock has been relatively mixed recently, with a 7.8% return year to date and 3.8% over the last year, alongside a 4.3% decline over the past week and a 1.4% gain over the last 30 days. These movements can change how the market is thinking about its risk and opportunity. Recent coverage has...
NYSE:USPH
NYSE:USPHHealthcare

A Look At U.S. Physical Therapy’s Valuation As Shares Pull Back And P/E Stands At 53.9x

Setting the scene on U.S. Physical Therapy With no fresh headline event driving U.S. Physical Therapy (USPH) today, investors are left weighing a share price of $76.83 alongside recent return figures and the company’s latest reported revenue and net income. See our latest analysis for U.S. Physical Therapy. The recent share price pullback, including a 1-day share price return of 1.35% decline and a 30-day share price return of 11.63% decline, sits alongside a 1-year total shareholder return...
NasdaqGS:SVCO
NasdaqGS:SVCOSoftware

Is Silvaco Group’s (SVCO) New MIPI IP Rollout Enough To Reframe Its Loss-Making Profile?

In March 2026, Silvaco Group, Inc. completed a follow-on at-the-market US$15 million common stock offering and reported full-year 2025 revenue of US$63.06 million with a net loss of US$41.21 million, alongside guidance for first-quarter 2026 revenue of US$15 million to US$19 million. A few days earlier, the company also announced the immediate availability of Mixel MIPI Production Ready Offerings, broadening its silicon-proven mixed-signal interface IP portfolio across advanced process nodes...
NasdaqGM:EH
NasdaqGM:EHAerospace & Defense

Did EHang’s Q4 Profit Amid Full-Year Losses Just Shift EHang Holdings’ (EH) Investment Narrative?

EHang Holdings Limited reported its fourth-quarter 2025 results on March 12, 2026, with sales rising to CNY 243.78 million and quarterly net income reaching CNY 10.49 million, while full-year 2025 revenue increased to CNY 509.50 million alongside a full-year net loss of CNY 230.54 million. The shift from a quarterly net loss in the prior year to profitability in Q4 2025, even as the full year remained loss-making, highlights a meaningful improvement in operating performance and cost...
NasdaqGM:CRVS
NasdaqGM:CRVSBiotechs

A Look At Corvus Pharmaceuticals (CRVS) Valuation After Recent Share Price Swings

Corvus Pharmaceuticals stock moves after recent performance swings Corvus Pharmaceuticals (CRVS) has been drawing fresh attention as its share price reflected sharp recent moves, including a 4.3% decline over the past day and a month return that is roughly 17.9% lower. See our latest analysis for Corvus Pharmaceuticals. Even with the latest 4.3% one day share price decline and a softer 30 day share price return of 17.9%, Corvus Pharmaceuticals still shows strong upward momentum, with a 90 day...
NYSE:FE
NYSE:FEElectric Utilities

Does FirstEnergy’s Massive Storm Restoration Test Meaningfully Shift the Bull Case for FE?

In early March 2026, FirstEnergy faced a severe windstorm across Ohio, Pennsylvania, West Virginia and Maryland, initially cutting power to about 655,400 customers before restoring service to nearly 478,000 within one day as crews and external teams worked continuously. The scale and speed of this restoration effort highlight how FirstEnergy’s operational readiness and grid resilience practices are tested in real-world conditions that matter to both customers and investors. Now we’ll examine...
NYSE:THR
NYSE:THRElectrical

Does Upgraded 2026 Guidance And Institutional Buying Change The Bull Case For Thermon Group Holdings (THR)?

Recently, Thermon Group Holdings reported strong fiscal third-quarter results, including about US$147 million in revenue and a 14% rise in new orders to US$158.2 million, leading management to raise full-year 2026 revenue guidance to US$516–526 million and adjusted EBITDA guidance to US$114–120 million. At the same time, institutional investor Clifford Capital Partners expanded its position by acquiring 414,006 shares, a move that underscores growing confidence in Thermon’s industrial...
NYSE:HRI
NYSE:HRITrade Distributors

Is Herc Holdings (HRI) Pricing Reflect Its Cash Flow Outlook After Recent Share Price Jump

If you are wondering whether Herc Holdings' current share price reflects its true worth, this article will walk through what the numbers are actually saying about value. The stock recently closed at US$108.91, with returns of 9.1% over 3 years and 18.8% over 5 years. More recent periods have been weaker, with a 7 day return of 9.3%, 30 day return of 37.1%, year to date return of 28.5% and 1 year return of 14.0%. Recent coverage has focused on Herc Holdings as a US equipment rental company...
NasdaqGS:KYIV
NasdaqGS:KYIVWireless Telecom

Why Kyivstar Group (KYIV) Is Down 6.8% After Mixed 2025 Earnings and 2026 Growth Guidance

Earlier this week, Kyivstar Group Ltd. reported its full-year 2025 results, with sales rising to US$1,157 million from US$919 million, even as net income fell to US$124 million from US$283 million and basic EPS from continuing operations declined to US$0.57 from US$1.37. The company also issued 2026 guidance calling for USD revenue growth of 8%–11%, underlining management’s confidence in further expanding its fast-growing digital and connectivity ecosystem despite a volatile operating...
NYSE:SHO
NYSE:SHOHotel and Resort REITs

Assessing Sunstone Hotel Investors (SHO) Valuation After Prolonged Weak Share Price Performance

Why Sunstone Hotel Investors Is Back on Investors’ Radar Sunstone Hotel Investors (SHO) is drawing fresh attention after a stretch of weaker share performance, with the stock showing negative returns over the past week, month, past 3 months, year, and 5 years. At the same time, the lodging focused real estate investment trust reports annual revenue of US$960.1 million and net income of US$8.2 million. These figures give investors a starting point for assessing how the current share price...
NasdaqCM:AHG
NasdaqCM:AHGHealthcare

Akso Health Group (AHG) Is Up 85.2% After 75.6% Revenue Surge And New 52-Week High - Has The Bull Case Changed?

Akso Health Group recently reported revenue growth of 75.6%, coinciding with its shares reaching a fresh 52-week high in past trading. This combination of rapid top-line expansion and a record-year price level highlights how operational momentum can reshape perceptions of the company’s prospects. Next, we will examine how this rapid revenue growth influences Akso Health Group’s investment narrative in light of its recent share price gains. We've uncovered the 14 dividend fortresses yielding...
NasdaqGS:AUR
NasdaqGS:AURSoftware

Is Aurora Innovation (AUR) Pricing Reflect Its Autonomous Trucking Ambitions After Recent Share Decline

If you are wondering whether Aurora Innovation's current share price reflects its true potential, this article walks through what the numbers actually say about value. The stock closed at US$4.08 recently, with a 7 day return of a 9.1% decline, a 30 day return of an 8.9% decline, a 5.4% gain year to date, and a 41.5% decline over the past year, while the 3 year return is very large. Recent market attention has focused on Aurora Innovation's role in autonomous driving technology and...
NasdaqCM:TSSI
NasdaqCM:TSSIIT

A Look At TSS (TSSI) Valuation After Strong Q4 Results And Amended AI Rack Agreement

TSS (TSSI) drew fresh attention after reporting fourth quarter 2025 results, with revenue of US$60.91 million and net income of US$12.16 million, alongside an amended AI rack integration agreement. See our latest analysis for TSS. The latest earnings beat and AI rack integration update come after a sharp run in the shares, with a 31.90% 7 day and 46.81% 30 day share price return. The 1 year total shareholder return of 23.83% and very large 3 year total shareholder return suggest momentum has...
NYSE:CIVI
NYSE:CIVIOil and Gas

How Investors Are Reacting To Civitas Resources (CIVI) Softer Earnings And Debt Tender Offer

Civitas Resources previously reported full-year 2025 results showing revenue of US$4,393 million and net income of US$561 million, both lower than the prior year, while SM Energy, which assumed Civitas’s 8.375% Senior Notes due 2028 after their merger, launched a cash tender offer for up to US$750 million of those notes. This combination of softer earnings and an offer to repurchase a large portion of high-coupon debt highlights how the merged business is balancing profitability pressures...
NasdaqGS:ATEC
NasdaqGS:ATECMedical Equipment

Assessing Alphatec Holdings (ATEC) Valuation After Recent Share Price Weakness

What recent performance suggests about Alphatec Holdings shares Alphatec Holdings (ATEC) has drawn investor attention after a mixed run, with the stock down about 8% over the past month and roughly 38% in the past 3 months. See our latest analysis for Alphatec Holdings. The recent 1 day share price return of a 1.76% decline and 7 day gain of 0.41% sit against a much weaker backdrop, with the 90 day share price return of a 37.7% decline and year to date share price return of a 40.85% decline...